Journalism begins where hype ends

,,

I visualise a time when we will be to robots what dogs are to humans, and I’m rooting for the machines."

—Claude Shannon

Anthropic Claims Frontier Claude Models Outperform Traditional Protein Design Campaigns

Anthropic’s Claude models designed de novo protein binders against 14 of 15 targets with a 27% hit rate—exceeding the typical 10–15%—in independent lab tests by Adaptyv Bio and Twist Bioscience.

Anthropic says the process is an early foundational step in drug discovery / development and they are now training Claude to run the entire drug development process end-to end